This study examines transcriptional dysregulation of autophagy in Duchenne muscular dystrophy, highlighting FoxO and TFEB suppression and resveratrol's therapeutic role.
This research explores differentially expressed genes (DEGs) and hub genes in Duchenne muscular dystrophy, analyzing their role in disease progression and treatment targets.
This article provides essential terminology for understanding muscular dystrophy research, covering key scientific terms such as cohort studies and exome sequencing.
This review explores exon skipping therapy for Duchenne muscular dystrophy, discussing preclinical and clinical trials, therapeutic challenges, and future developments.
This article explains exon skipping, a genetic technique for treating Duchenne muscular dystrophy (DMD) by restoring the dystrophin protein using antisense oligonucleotides.
This review examines dysferlinopathies, highlighting clinical features, molecular mechanisms, genetic therapies, and the latest research in treatment development.
This study examines the role of Wnt7a in muscle regeneration, highlighting its necessity for muscle repair and its potential as a therapy for Duchenne muscular dystrophy.
This study presents an optimized protocol for isolating extracellular vesicles (EVs) from regenerating muscle tissue using TFF and SEC, ensuring purity and efficiency.
This article explores the role of satellite cell heterogeneity in skeletal muscle homeostasis, highlighting its impact on muscle repair, self-renewal, and differentiation.